![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
Palvella’s reverse merger with Pieris; AbbVie’s VC arm invests in anti-aging startup
Plus, news about Verastem and OSE Immunotherapeutics:
Palvella inks reverse merger: The skin diseases biotech plans to take the Nasdaq spot …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.